肾衰竭合并脑出血应用无肝素血液透析治疗的可行性研究

Feasibility Study of Application of Non-heparin Hemodialysis on Treatment of Renal Failure with Cerebral Hemorrhage

为探讨肾衰竭合并脑出血应用无肝素血液透析治疗效果,并对其安全性及可行性做出客观评价,随机抽取在我院接受治疗的66例肾衰竭合并脑出血患者,根据治疗方法对患者进行分组。其中,对照组患者接受单纯无肝素血液透析治疗,观察组患者实施无肝素序贯血液透析治疗,比较两组患者治疗效果。观察组脑出血治疗总有效率明显高于对照组;观察组患者治疗7d、14d时,各项指标恢复情况明显优于对照组,两组差异具有统计学意义（P〈0.05）。说明无肝素血液透析治疗是肾衰竭合并脑出血患者的主要治疗方法,其中无肝素序贯血液透析方法可明显缓解患者不良症状,与单纯疗法相比更具使用价值,可对患者预后产生积极效果,值得进行临床推广。

o investigate treatment effect of applying non-heparin hemodialysis on renal failure with cerebral hemorrhage, and to make an objective evaluation of its safety and feasibility, this paper randomly selected 66 cases of renal failure patients with cerebral hemorrhage treated in our hospital, according to the treatment method patients were grouped. Among them, the control group received non-heparin hemodialysis treatment alone, the observation group with non-sequential heparin hemodialysis treatment, treatment effects were compared.The total effective rate of observation group with cerebral hemorrhage treatment was significantly higher; after observation group patients treated for 7d and 14 d, the recovery of indicators were better than the control group, the difference was statistically significant（P 0.05）.Non-heparin hemodialysis therapy is the main treatment for renal failure patients with cerebral hemorrhage, non-heparin hemodialysis sequential method can significantly alleviate the negative symptoms of patients, which have more value compared with the simple therapies and can make a positive effect on the prognosis of patients, therefore it is worth promoting.